Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease [Phase 3]

View source ↗

Summary

This trial update notes the completion of a Phase 3 randomized, double-blind, placebo-controlled multicenter trial. It evaluated the safety and efficacy of ceft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Drugs mentioned

• Doxycycline (Doxycycline)
• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Lyme Disease | Phase 3 | Status: COMPLETED